Nature
Study
May 2001
For professionals
One of two papers published together in 2001 that found the first gene firmly linked to Crohn's, NOD2. A change in this gene produces a faulty version of a protein that normally helps the immune system recognise bacteria. It pointed to an abnormal reaction to gut bacteria as part of what causes Crohn's.
Topics
About Crohn's disease
Research
Jargon explained
NOD2
mutation
susceptibility gene
innate immunity
Nature
Study
Nov 2012
For professionals
A huge international genetics study that mapped many gene regions linked to Crohn's and colitis. Many of these are shared with other immune conditions such as ankylosing spondylitis and psoriasis, and with the body's response to bacteria such as those that cause TB. It shows IBD risk is spread across many genes, each adding a small amount.
Topics
About Crohn's disease
Research
Jargon explained
genome-wide association study
locus
immune-mediated disease
Nature
Study
May 2001
For professionals
The companion to the other 2001 NOD2 paper. It found several variants of the NOD2 gene linked to Crohn's, all in the part of the protein that senses bits of bacteria. It suggested that people with these variants may handle gut bacteria differently, a key step in understanding the causes of Crohn's.
Topics
About Crohn's disease
Research
Jargon explained
NOD2
gene variant
genetic susceptibility
NIHR BioResource
Web page
Patients and professionals
A national NIHR project that builds a large panel of people with Crohn's and colitis who agree to share samples and health data and to be invited into future studies. It aims to understand the genetic causes of IBD and why people respond differently to treatment. There is also a children's arm.
Topics
Research
Jargon explained
bioresource
cohort
genetic analysis
NHS
Web page
Dec 2022
For patients
The NHS explains what a clinical trial is and how to find one. It suggests asking your doctor or a patient organisation, and points to the Be Part of Research website, where you can search UK studies and contact researchers.
Topics
Research
Jargon explained
clinical trial
randomised
Crohn's & Colitis UK
Web page
Jul 2026
For patients
Explains how new IBD medicines move from lab testing through clinical trials to licensing, and describes medicines currently in late-stage testing.
Topics
Research
Medicines
Jargon explained
clinical trial
licensing
phase 3
US National Library of Medicine
Tool
Patients and professionals
The largest worldwide database of clinical studies, run by the US government. It includes many trials running at UK hospitals, often drug-company trials of new Crohn's medicines. Each record lists the study's aim, who can join and where.
Topics
Research
Jargon explained
clinical trial
eligibility criteria
trial registry
NCT number
The Lancet
Study
Dec 2017
Patients and professionals
CALM compared deciding treatment on symptoms alone with 'tight control', where treatment was stepped up if blood or poo tests (CRP and faecal calprotectin) showed inflammation even when people felt fine. After 48 weeks, 46% in the tight control group had a healed bowel lining compared with 30% in the symptom-only group. It is a cornerstone of the 'treat to target' approach.
Topics
Monitoring
Biologics and newer medicines
Research
Jargon explained
tight control
faecal calprotectin
CRP
mucosal healing
treat to target
NIHR
Tool
For patients
The NHS research service's search tool for finding health studies to take part in across the UK. Searching for Crohn's disease lists studies currently recruiting, with who can join and where. A good first stop if you want to volunteer for a trial.
Topics
Research
Jargon explained
clinical trial
recruiting
The Lancet
Study
May 2022
Patients and professionals
Two trials testing risankizumab (Skyrizi) drips to bring active Crohn's under control, including in people for whom other biologics had failed. Risankizumab led to more remissions, and more improvement seen on camera tests of the bowel, at 12 weeks than placebo, and was generally well tolerated.
Topics
Biologics and newer medicines
Jargon explained
induction
phase 3 trial
endoscopic response
NICE CKS
Guide
May 2024
For professionals
Explains that no single cause of Crohn's has been proven and that it is thought to be an immune-driven condition set off by environmental triggers in people whose genes make them susceptible. It covers family history, smoking (which raises the risk of Crohn's, unlike UC, and is linked to flare-ups and surgery), a past bout of infectious gastroenteritis and other factors that have been studied.
Topics
About Crohn's disease
Research
Jargon explained
immune-mediated
gastroenteritis
appendicectomy
Cochrane
Systematic review
Feb 2019
Patients and professionals
Reviewed trials of special diets (such as low-sugar, low-red-meat or exclusion diets) for Crohn's and colitis. The effects were uncertain and no firm conclusions could be drawn. The authors say experts need to agree what the diets should contain and more trials are needed.
Topics
Diet and nutrition
Jargon explained
dietary intervention
randomised controlled trial